Bio Pharma Dive
OCTOBER 14, 2020
The Swiss pharma is the third large drugmaker to partner with Harvard spinout Dyno Therapeutics, a small biotech aiming to improve gene therapy technology.
Pharma Mirror
OCTOBER 14, 2020
Histoplasmosis is an inflammatory lung infection that usually occurs when a human has had contact with bird or bat droppings. Histoplasmosis is similar in symptoms to COVID-19, such as shortness of breath, fever, chest pain, and coughing. Some people who are at high-risk for histoplasmosis may also be concerned that they have contracted COVID-19. Though.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
OCTOBER 14, 2020
Safety signals in a mid-stage study led Vertex to stop work on one of its experimental drugs for the inherited disorder alpha-1 antitrypsin deficiency.
BioSpace
OCTOBER 14, 2020
Eli Lilly is betting on a new approach to axonal degeneration, announcing a definitive agreement to acquire Disarm Therapeutics, a privately-held biotech company committed to solving this mystery.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Bio Pharma Dive
OCTOBER 14, 2020
Research for the drug, now cleared as Inmazeb, helped Regeneron jumpstart its fast development of an antibody therapy for COVID-19.
VirTrial
OCTOBER 14, 2020
AUSTIN, TEXAS (PRWEB) OCTOBER 14, 2020. BlueCloud® by HealthCarePoint (HCP) and VirTrial today announced a global collaboration that will enable international investigator sites to become VirTrial technology competent and ready for the benefit of Sponsors, CROs, Universities, regulatory agencies and other industry stakeholders, and ultimately patients.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
XTalks
OCTOBER 14, 2020
There are various ways to detect and diagnose COVID-19, including PCR-based tests and antigen diagnostics. But in some parts of the world, dogs are being used to sniff out COVID-19 positive patients. In Australia, a springer spaniel named Floki is being studied by scientists at the University of Adelaide. They are training the canine to detect signs of coronavirus infection in human sweat, with aims of using dogs to screen people for COVID-19.
Scienmag
OCTOBER 14, 2020
New applications for organoids from human intestinal tissue Credit: E. Rath / TUM The human intestine is vital for both digestion and absorbing nutrients as well as drugs. For any type of research that involves intestines, scientists require research models that reflect the physiological situation inside human beings with the highest possible accuracy.
pharmaphorum
OCTOBER 14, 2020
There is growing evidence that the coronavirus may be able to re-infect patients, and a new instance of a second infection has been confirmed in the US. . It is the fifth confirmed reinfection worldwide after at least four other cases were confirmed in Belgium, the Netherlands, Hong Kong and Ecuador. The latest case was recorded in the Lancet Infectious Diseases journal and involved a 25 year-old man with no known immune disorders or underlying conditions.
Scienmag
OCTOBER 14, 2020
Credit: This figure appears in the publication in Molecular Biology and Evolution. In 1998, ocean temperatures soared, and the world experienced its first significant coral bleaching event. From the Great Barrier Reef to Indonesia to Central America, corals turned white and ghostly. Many of them died. And this was just a hint as to what […].
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
BioSpace
OCTOBER 14, 2020
Vertex Pharmaceuticals announced that after early data on its Phase II trial of VX-814 in Alpha-1 antitrypsin deficiency (AATD), it is halting the trial and ending development of the drug.
Scienmag
OCTOBER 14, 2020
Dairy production in developing countries highlighted in November issue of the Journal of Dairy Science® Credit: Adesogan, A.T. and G.E. Dahl. 2020. MILK Symposium Introduction: Dairy production in developing countries. J. Dairy Sci. 103:9677-9680. [link] Philadelphia, October 15, 2020 – Low dairy consumption is common among low- and middle-income countries (LMICs); however, with the demand […].
BioSpace
OCTOBER 14, 2020
Astellas Pharma is building on a 2019 collaborative relationship and snapping up California-based iota Biosciences and that company’s bioelectronics technology in order to accelerate its Rx+ business.
Scienmag
OCTOBER 14, 2020
For many non-English speakers, language is a hindrance to full participation in science Credit: Photo courtesy of Valeria Ramírez-Castañeda English has become the de facto language of science: International conferences are held in English, the world’s top scientific journals are in English and academics in non-English speaking countries get promoted based on their publications in […].
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
pharmaphorum
OCTOBER 14, 2020
A lack of clear information on COVID risk is stopping people with long-term conditions accessing the care they need – and could be storing up problems for the future. People living with long-term health conditions have been missing vital tests and monitoring because they fear contracting the novel coronavirus. A survey carried out by the Patient Information Forum (PIF), and supported by Norgine, this summer found that almost one in three respondents had delayed accessing care during the pandemic
Scienmag
OCTOBER 14, 2020
If you’ve ever wondered how to relax a cow, this one’s for you Credit: © Institute of Animal Welfare Science, Vetmeduni Vienna After months of technology-based communication enforced by COVID-19, many of us are missing a “live” human voice. But we’re not the only ones — a new study reveals that cows also prefer a […].
BioSpace
OCTOBER 14, 2020
Putin touts efficacy and safety of new vaccine without the data to back him up.
Scienmag
OCTOBER 14, 2020
Cedars-Sinai emergency department researchers confirm the safety of home discharge for low-risk patients with COVID-19 Credit: Photo by Cedars-Sinai LOS ANGELES (Oct. 12, 2020) — A new study shows that the vast majority of patients who visited the Ruth and Harry Roman Emergency Department at Cedars-Sinai with suspected COVID-19 (novel coronavirus) symptoms, and who were […].
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
BioSpace
OCTOBER 14, 2020
Several biopharmaceutical companies have made headway as of late in the race to develop a vaccine for COVID-19, which is responsible for the current global pandemic.
Scienmag
OCTOBER 14, 2020
MU researcher helps adolescents with autism transition to adult health care Credit: MU School of Health Professions COLUMBIA, Mo. — Independence has always been a driving force in Nancy Cheak-Zamora’s life. Now an associate professor at the University of Missouri School of Health Professions, she grew up undiagnosed with dyslexia, a learning disorder that can […].
NY Times
OCTOBER 14, 2020
Experts were comforted that companies are following safety precautions. They pointed out that pauses in vaccine trials are common, but pauses in treatment trials like Eli Lilly’s are rare.
BioSpace
OCTOBER 14, 2020
This week, the judge overseeing her trial denied all efforts from her legal team to dismiss more than a dozen criminal charges against the Theranos founder.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Scienmag
OCTOBER 14, 2020
New metric can help determine when birds fly over a site or stop to refuel or rest Credit: Colorado State University/ Kyle Horton Each spring, billions of land birds — thrushes, warblers, orioles, tanagers, and more — migrate through the night, navigating the coast of the Gulf of Mexico. Even greater numbers migrate in the […].
BioSpace
OCTOBER 14, 2020
While COVID-19 tests have been crucial in identifying and tracking cases of infection and disease-related morbidity and mortality, they aren’t without their potential drawbacks.
Pharma Times
OCTOBER 14, 2020
Data demonstrated a 90% successful lumbar vertebrae fusion rate at 24 months
Scienmag
OCTOBER 14, 2020
The way leaves reflect light can illuminate the evolutionary history of seed plants, according to an international team of scientists led by a University of Maine researcher. Plant reflectance spectra, or the light profile leaves reflect across different wavelengths, capture the change and diversification of seed plants as a result of evolution, according to Dudu […].
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Outsourcing Pharma
OCTOBER 14, 2020
The federal government continues to offer life-sciences professionals advice and resources as they pursue treatments to help fight the COVID-19 virus.
Scienmag
OCTOBER 14, 2020
The discovery, reported in the journal Nature, opens door for reimagining the energy grid, technology, society Credit: Josh Hawkins/UNLV Photo Services Physicists from the University of Nevada, Las Vegas and the University of Rochester have made a breakthrough in the long sought-after quest for a room-temperature superconductor, what they call the “holy grail” of energy […].
BioPharma Reporter
OCTOBER 14, 2020
Enrollment is temporarily on hold in the ACTIV-3 clinical trial, which is evaluating Lilly's investigational neutralizing antibody bamlanivimab (LY-CoV555) as a treatment for COVID-19 in hospitalized patients. The pause was recommended by the study's independent Data and Safety Monitoring Board (DSMB).
Scienmag
OCTOBER 14, 2020
As world focuses on dual crises of climate change and biodiversity loss, landmark report is the first of its kind to pinpoint the ecosystems that should be restored for the biggest climate and biodiversity benefits-at the lowest cost London (14 October 2020)–Returning specific ecosystems in all continents worldwide that have been replaced by farming to […].
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
339 
Let's personalize your content